Effect of Tricalcium Phosphate on Healing of Non-Unions: An Observational Study of over 400 Non-Unions
DOI: https://doi.org/10.2147/TCRM.S409119
2023-05-12
Therapeutics and Clinical Risk Management
Abstract:Thomas Ferbert, Christina Münch, Sebastian Findeisen, William Pauly, Matthias Miska, Tobias Grossner, Michael C Tanner, Gerhard Schmidmaier, Lars Helbig Clinic for Trauma and Reconstructive Surgery, Center for Orthopedics, Trauma Surgery and Spinal Cord Injury, Heidelberg University Hospital, Heidelberg, D-69118, Germany Correspondence: Lars Helbig, Clinic for Trauma and Reconstructive Surgery, Center for Orthopedics, Trauma Surgery and Spinal Cord Injury, Heidelberg University Hospital, Schlierbacher Landstrasse 200a, Heidelberg, D-69118, Germany, Tel +496221/5635371, Fax +496221/5626300, Email Purpose: A central aspect of the treatment of non-unions is the filling of bone defects. The quantity of available autologous bone for this purpose is limited. Alternatively, or additionally, bone substitutes may be used. The aim of this retrospective, single-center study including 404 non-unions in 393 patients is to investigate the effect of tricalcium phosphate (TCP) on the healing of non-unions. Furthermore, the influence of gender, age, smoking status, comorbidities, type of surgical procedure, presence of infection, and length of treatment was investigated. Methods: We evaluated three groups of patients. Group 1 received TCP + BG, group 2 received BG alone and group 3 received no augmentation. Bone stability was assessed 1 and 2 years after non-union revision surgery through analysis of radiographs using the Lane Sandhu Score. Scores ≥ 3 were rated as stable Other influencing factors were collected from the electronic medical record. Results: In 224 non-unions, bone defects were filled with autologous bone and TCP (TCP+BG). In 137 non-unions, bone defects were filled with autologous bone (BG), and in 43 non-unions presenting non-relevant defects, neither autologous bone nor TCP were used (NBG). After 2 years, 72.7% of the TCP+BG patients, 90.1% of the BG patients and 84.4% of the NBG patients achieved a consolidation score ≥ 3. Advanced age, presence of comorbidities and longer treatment period had a significantly negative effect on consolidation 1 year after surgery. Longer treatment periods also showed a negative significant effect after 2 years. It is notable that larger defects, mainly treated with the combination of autologous bone and TCP, showed similar healing rates to that of smaller defects after 2 years. Conclusion: The combination of TCP and autologous bone-grafts shows good results in the reconstruction of complicated bone-defects, but patience is required since the healing period exceeds 1 year in most patients. Keywords: non-unions, bone substitute, Lane Sandhu Score, tricalcium phosphate Non-union occurs in up to 10% of long bone fractures 1 with current data from Germany suggesting an increase in upcoming years 2 and surgical treatment therefore remaining a major challenge. The "Diamond Concept" was established 15 years ago 3 and describes key elements of fracture healing. Mechanical stability, vascularization, osteoinductive factors, osteoconductive matrix and osteogenic cells have also shown to have an important role in non-union therapy. 4,5 In non-union surgery, the Masquelet procedure has shown good results. In a multi-step surgery, non-union is resected, infection is controlled, and local application of bone-cement (polymethyl methacrylate) induces a well-vascularized membrane to sustain the future bone graft. During the final step, bone cement is removed and the resulting defect is reconstructed with either autologous bone graft, synthetic bone graft or a combination of both. 6 This multi-stage procedure offers the possibility of repeated debridements of necrotic bone tissue, therefore achieving superior infection control and vascularization. 7 Although it is affective, this procedure comes at the cost of generating significant bone defects. While treating residual bone defects, the choice of procedure and type of bone graft is defined by individual patient characteristics as well as by the nature of the non-union defect itself. Age, smoking, comorbidities, length of treatment, presence of infection and gender 8–10 all count amongst patient-specific factors described in literature as having an influence on healing outcome. Autologous bone graft has been considered the gold standard in non-union therapy since it is the only material known to posess osteoinductive properties. 11 Defect augmentation with autologous bone graft is performed with cancellous bone obtained through sampling of the iliac crest bone or using a reaming apparatus capable of harvesting large volumes of intramedullar bone graft: the RIA-System. 12 To support adequate bone healing, synthetic bone graft should ideally be osteogenic, osteoconduct -Abstract Truncated-
health care sciences & services